Founded by neuroscientists Iftach Dolev, PhD, and Hilla Fogel, PhD, QuantalX develops neurodiagnostic technology that measures brain-network function in real time. Its Delphi-MD system combines focused magnetic stimulation, electrophysiological recording, and algorithmic analysis to give clinicians quantitative functional insights alongside conventional evaluation. The FDA De Novo-authorized platform is used in clinics and research sites across Europe, Asia, and North America.
FDA De Novo Authorization for Delphi-MD™
certification
Neurosteer IncFounded in 2015 by Tel Aviv University professor Nathan Intrator, Neurosteer develops a wearable, medical-grade brain-activity interpretation platform built around a pocket-sized, single-channel EEG monitor. Its wireless forehead sensor and cloud-based analysis provide real-time brain metrics for clinical assessment, continuous monitoring and research, and the device has FDA Class II clearance. Neurosteer’s teams work across New York, California and Israel, drawing on expertise in neuroscience and signal processing.NEW YORK, NY
BrainScope Company, IncFounded in 2006, BrainScope develops medical neurotechnology that converts brain electrical activity (EEG) into objective, point-of-care assessments for brain health. Its FDA-cleared system was the first AI/machine-learning medical device cleared in neurology and is used to assess head injuries for the likelihood of brain bleeds and concussion without radiation. The company is now extending its EEG-based platform into digital biomarkers for conditions including stroke and cognitive decline.ROCKVILLE, MD
Firefly Neuroscience, IncFirefly Neuroscience is a healthcare technology company focused on bringing direct measurement of brain function into routine clinical care. Its FDA-cleared Evoke™ system helps clinicians interpret brain activity alongside clinical evaluation, giving providers a clearer basis for decisions involving neurological and behavioral conditions.BUFFALO, NY
Bio-Signal Group CorpFounded in 2002 by NYU neuroscientist André Fenton, Bio-Signal Group Corp. develops portable neurodiagnostic equipment and software that bring clinical-grade EEG testing beyond the traditional hospital lab. Its FDA-cleared microEEG® system can be set up in about five minutes without a specialized EEG technician, with cloud-based interpretation enabling board-certified neurologists to read studies remotely in less than an hour. The company’s work serves settings ranging from emergency departments and physician practices to sports concussion management.BROOKLYN, NY